SF3B1, RUNX1 and TP53 Mutations Significantly Impact the Outcome of Patients With Lower-Risk Myelodysplastic Syndrome
| Autor: | Falantes, Jose F., Márquez-Malaver, Francisco J., Carrillo, Estrella, Culebras, Marta García, Morales, Rosario, Prats, Concepción, Vargas, Maria T., Caballero, Teresa, Rodríguez-Arbolí, Eduardo, Espigado, Ildefonso, Pérez-Simón, Jose Antonio |
|---|---|
| Zdroj: | In Clinical Lymphoma, Myeloma and Leukemia December 2022 22(12):e1059-e1066 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect